Author Details
( * ) denotes Corresponding author
Nanoparticle-based drug delivery systems have emerged as promising alternatives to conventional therapies due to their ability to provide targeted, controlled, and sustained drug release with minimal systemic toxicity. Among these systems, superparamagnetic iron oxide nanoparticles (SPIONs) have gained considerable attention for cancer therapy because of their magnetic responsiveness, biocompatibility, and imaging potential. The present study focuses on the formulation and optimization of SPION-based drug delivery systems for targeted anticancer therapy. SPIONs were synthesized using a co-precipitation method and surface-modified with biocompatible polymers to improve stability and circulation time. The nanoparticles were characterized for particle size, morphology, zeta potential, polydispersity index, entrapment efficiency, magnetic properties, and in vitro drug release behavior using DLS, SEM/TEM, XRD, and UV-visible spectrophotometry. The optimized formulation demonstrated nanoscale particle size with narrow size distribution, high drug entrapment efficiency, and sustained drug release characteristics. Enhanced cellular uptake and magnetic targeting efficiency indicated improved therapeutic potential. The study concludes that SPIONs represent an effective platform for targeted cancer drug delivery with reduced adverse effects and improved therapeutic efficacy.
Keywords
Superparamagnetic Iron Oxide nanoparticles; Targeted drug delivery; Entrapment efficiency; Surface modification; Co-precipitation synthesis; Cancer therapy
Abstract Views: 1
PDF Views: 3